Genprex Granted Patent for Reqorsa Gene Therapy in Cancer Treatment
Genprex announced that The Israel Patent Office has granted Genprex a patent covering the use of Reqorsa Gene Therapy in combination with PD-1 antibodies for the treatment of cancer. This patent will expand on the previously granted patents for REQORSA in combination with PD-1 antibodies, which have been granted in the U.S., Japan, Mexico, Russia, Australia, Chile, China, Singapore and Europe.
